Results 231 to 240 of about 191,310 (286)

Inhibition of stimulated bone resorption in vitro by TIMP-1 and TIMP-2

Biochimica Et Biophysica Acta - Molecular Cell Research, 1993
Recombinant human TIMP-1 and TIMP-2 (tissue inhibitors of metalloproteinases) inhibited bone resorption induced by either parathyroid hormone or 1,25-dihydroxyvitamin D3 in cultured neonatal mouse calvariae. The inhibition was reversible, dose-dependent and complete at 1 microgram/ml inhibitor concentration. TIMP-2 was more potent than TIMP-1.
P A, Hill, J J, Reynolds, M C, Meikle
exaly   +3 more sources

Engineering of Selective TIMPs

Annals of the New York Academy of Sciences, 1999
ABSTRACT: Differences in proteinase susceptibility between free TIMP‐1 and the TIMP‐1‐MMP‐3 complex and mutagenesis studies suggested that the residues around the disulfide bond between Cys1 and Cys70 in TIMP‐1 may interact with MMPs. The crystal structure of the complex between TIMP‐1 and the catalytic domain of MMP‐3 has revealed that the α‐amino ...
H, Nagase   +7 more
openaire   +2 more sources

TIMPs as multifacial proteins

Critical Reviews in Oncology/Hematology, 2004
Tissue inhibitors of metalloproteinases (TIMPs) are natural inhibitors of matrix metalloproteinases (MMPs) found in most tissues and body fluids. By inhibiting MMPs activities, they participate in tissue remodeling of the extracellular matrix (ECM). The balance between MMPs and TIMPs activities is involved in both normal and pathological events such as
Elise, Lambert   +3 more
openaire   +2 more sources

Clinicopathological correlations of TIMP‐1 and TIMP‐2 in Hodgkin's lymphoma

European Journal of Haematology, 2003
Abstract:Objectives:  The influence of matrix–tumour interactions in Hodgkin's lymphoma is poorly characterised, although a large part of the tumour often consists of reactive tissue. The aim of the present study was to assess the clinicopathological role of two main inhibitors of matrix metalloproteinases, TIMP‐1 and TIMP‐2, in Hodgkin's lymphoma ...
Heli, Pennanen   +3 more
openaire   +2 more sources

TIMP-1 and TIMP-2 Levels in Vitreous and Subretinal Fluid

Japanese Journal of Ophthalmology, 1998
To understand the role of tissue inhibitors of metalloproteinase-1 and -2 (TIMP-1 and TIMP-2) in intraocular diseases, levels of TIMP-1 and TIMP-2 were measured by enzyme immunoassay in 47 patients with various ocular diseases: in subretinal fluid of 7 patients with rhegmatogenous retinal detachment and in vitreous of 12 patients with proliferative ...
T, Matsuo   +3 more
openaire   +2 more sources

Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas

Current Eye Research, 1998
Determine the tissue distribution patterns for tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2, TIMP-3), gelatinase A and gelatinase B in normal and pathologic corneas.Corneas were examined by immunohistochemistry, using antibodies to TIMP-1, TIMP-2, TIMP-3, gelatinase A or gelatinase B.In normal corneas, TIMP-1 antibody stained the epithelium ...
M C, Kenney   +5 more
openaire   +2 more sources

MMPs and TIMPs-An Historical Perspective

Molecular Biotechnology, 2002
There are currently 25 known vertebrate matrix metalloproteinases (MMPs) and 4 tissue inhibitors of metalloproteinases (TIMPs). This article reviews these proteases from an historical perspective in terms of who discovered each protein, when the sequence was established, when action on protein substrates was demonstrated, and what names have been used.
openaire   +3 more sources

Home - About - Disclaimer - Privacy